Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A. White KM, Rosales R, Yildiz S, Kehrer T, et al. Science 2021 Jan 25. pii: science.abf4058. doi: 10.1126/science.abf4058.

Read + Share

Amedeo Smart

Independent Medical Education

White KM, Rosales R, Yildiz S, Kehrer T, et al. Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A. Science 2021 Jan 25. pii: science.abf4058. doi: 10.1126/science.abf4058.
PMID: 33495306